Lesson 5 of 6 · 5 min

Regulation, region by region

In one paragraphA few peptides are approved medicines available on prescription. Most are not approved anywhere, are sold as "research chemicals" not intended for people, and in the EU and UK it is a criminal offence to sell them for human use. Enforcement has targeted sellers rather than buyers — but that is a description of practice, not a promise, and it varies by country.

Peptides fall into two legal worlds, and the same word covers both. In the first world are approved medicines — semaglutide, tirzepatide, tesamorelin in the US — that went through trials, were licensed by a regulator, and are prescribed by clinicians. In the second are compounds that have never been through that process: BPC-157, ipamorelin, epitalon, most of what is discussed online.

For the second group, the label "research use only" is doing a lot of work. It is a legal category, not a safety statement. It means the seller is declaring the product is not for people, which is what allows it to be sold at all. The moment a seller markets it for human use — muscle, healing, anti-ageing — they are, in the EU and UK, supplying an unlicensed medicine, which is a criminal offence.

In the European Union, most research peptides have no marketing authorisation. Selling them for human use is an offence for the seller; Europol coordinates website takedowns. In the United States, they are sold as research chemicals, and the FDA has separately barred several — BPC-157 and ipamorelin among them — from pharmacy compounding, citing safety uncertainty. The United Kingdom treats them as unlicensed medicines and the MHRA has been actively prosecuting sellers, especially of weight-loss injectables. Australia schedules most as prescription-only and enforces at the border; Canada has authorised none of the research-market compounds.

Two further categories catch people out. Approved elsewhere does not mean approved here: tesamorelin is a US prescription medicine and unauthorised in the EU. And sport has its own list: WADA prohibits growth-hormone secretagogues and releasing factors, BPC-157 and most of the rest at all times, regardless of legal status.

The pattern in enforcement so far is that it targets sellers, manufacturers and distribution networks rather than individual buyers. That is an observation about practice, and practice changes. It is not legal advice, and this site does not give any.

Take-away

"Research use only" is a legal label, not a safety rating.

Check

Regulation, region by region

Question 1 of 3

What does "research use only" on a label actually mean?

Pick one to continue